COVID-19 Update | September 3, 2021
Important Highlights

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020

Infection Control and Hospital Epidemiology (ICHE) published a paper September 2 authored by the CDC, which discusses the impact of the COVID-19 pandemic on the prevalence of healthcare-associated infections. Read SHEA’s press release along with a commentary authored by two SHEA leaders.
SHEA Coronavirus News

MySHEA Series – Approaches to Vaccination as a Condition of Employment in Healthcare

As part of the tool kit created as a companion resource for the Multisociety Statement, we have initiated a MySHEA series that opens a discussion every few days to get input on the ways members are approaching decisions involved in implementing COVID-19 vaccination as a condition of employment (CoE). We hope this series of forum discussions will help members learn about what other facilities are doing. The order of topics will follow those on the "Approaches" page of the tool kit, which will be updated as topics are covered. The first discussion of the series focused on timing, and the second, posted today, focuses on administration locations. For more information, log into MySHEA.
Technical Guidance, Standards, and Resources


FDA Approves First COVID-19 Vaccine (FDA)


Update on CDC COVID-19 vaccine safety monitoring systems: V-safe and VAERS (CDC)


Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine (Johnson & Johnson)


*UPDATE* Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States (CDC)


Strategies for Increasing Adult Vaccination Rates (CDC)


The Possibility of COVID-19 after Vaccination: Breakthrough Infections (CDC)


COVID-19 Vaccine Breakthrough Case Investigation and Reporting (CDC)



SARS-CoV-2 Variants Circulating in the US (CDC)



Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 (CDC MMWR)


Epidemiologically Linked COVID-19 Outbreaks at a Youth Camp and Men’s Conference — Illinois, June–July 2021 (CDC MMWR)


Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season (CDC MMWR)


Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021 (CDC MMWR)


SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status — Los Angeles County, California, May 1–July 25, 2021 (CDC MMWR)


COVID-19 Vaccination Coverage Among Adolescents Aged 12–17 Years — United States, December 14, 2020–July 31, 2021 (CDC MMWR)


Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School — Marin County, California, May–June 2021 (CDC MMWR)


COVID-19 Case Rates in Transitional Kindergarten Through Grade 12 Schools and in the Community — Los Angeles County, California, September 2020–March 2021 (CDC MMWR)


Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic — United States, February–March 2021 (CDC MMWR)


Special Settings and Populations

Update: COVID-19 Vaccination During Pregnancy (CDC)


COVID-19 Vaccines While Pregnant or Breastfeeding (CDC)


CDC launches COVID-19 resources for people with intellectual and developmental disabilities (CDC)


Clinical Care

Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19 (CDC)


Resumption in Use and Distribution of Bamlanivimab/Etesevimab in all U.S. States, Territories, and Jurisdictions (ASPR)


Shelf-Life Extension of Bamlanivimab under the Emergency Use Authorization for Bamlanivimab and Etesevimab Administered Together (ASPR)


Stakeholder Calls on COVID-19 Monoclonal Antibody Therapeutics (ASPR)


Occupational Health

List of Agencies and Organizations with COVID-19 Vaccination Condition of Employment Policies (SHEA)



Respiratory Protection Week 2021 (CDC)


Communication Resources

COVID-19 Monoclonal Antibody Therapeutics Communications Toolkit (ASPR)


Resource: FDA Approval Messaging and Outreach Tools (Public Health Communications Collaborative)


Misinformation Alerts (Public Health Communications Collaborative)


Payment and Reimbursement Policy

CMS Issued Guidance on COVID-19 Testing and Vaccine Expenditures (WHG)


Research and Resources Development Funding Opportunities
Information for Patients, Visitors, and the General Public 

*UPDATE* V-safe After Vaccination Health Checker (CDC)


*VIDEO* Families: Use v-safe after COVID-19 vaccination (CDC)


*NEW* COVID-19 Materials for People with Intellectual and Developmental Disabilities and Care Providers (CDC)


*NEW* A Guide for Caregivers (CDC)

Event Announcements

Authorities Associated with Respiratory Protection - The Role of NIOSH, the FDA, and OSHA

Sep 9, 3 PM ET


A webinar to clarify information regarding the U.S. Respiratory Protection authorities. a deeper dive into this subject and define each agency’s role. Speakers from NIOSH, the Food and Drug Administration (FDA) and the Occupational Safety and Health Administration (OSHA) will come together during NIOSH’s Respiratory Protection Week to provide an overview and discussion about the roles of these agencies during both conventional operations and emergency response scenarios.


2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines

Sep 9, 2 PM – 3 PM ET


During this COCA Call, presenters will provide updates on the Advisory Committee on Immunization Practices (ACIP) recommendations for the 2021-2022 influenza vaccination season and guidance for coadministration of influenza and COVID-19 vaccines.

Speakers: CAPT Lisa Grohskopf, MD, MPH, Andrew Kroger, MD, MPH

facebook-2.png twitterlogowhite.png